F-star appoints Dr Louis Kayitalire as Chief Medical Officer
CAMBRIDGE, England–(BUSINESS WIRE)– F-star, a clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy, today announces the appointment of Louis Kayitalire,...